CN Stock MarketDetailed Quotes
600645 Vcanbio Cell & Gene Engineering Corp.,Ltd.
- 20.15
- +0.18+0.90%
Trading Dec 18 14:03 CST
9.43BMarket Cap87.61P/E (TTM)
20.26High19.82Low56.62KlotVolume19.99Open19.97Pre Close113.68MTurnover1.21%Turnover Ratio88.77P/E (Static)467.95MShares24.0852wk High2.61P/B9.43BFloat Cap12.8852wk Low21.97Limit Up467.77MShs Float79.58Historical High17.97Limit Down2.20%Amplitude1.23Historical Low--Dividend TTM20.08Avg Price24.03KlotAsk--Div YieldTTM100Lot Size30.04KlotBid
Vcanbio Cell & Gene Engineering Corp.,Ltd. Key Stats
EPS
According to the latest financial report of Vcanbio Cell & Gene Engineering Corp.,Ltd., the latest earnings per share (TTM) for the company is 0.29. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Vcanbio Cell & Gene Engineering Corp.,Ltd.'s latest financial report to see how much their book value per share (BVPS) is currently at 7.73.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Vcanbio Cell & Gene Engineering Corp.,Ltd. shows that the company's current ratio is 1.66, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Vcanbio Cell & Gene Engineering Corp.,Ltd., the quick ratio is 1.48, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Vcanbio Cell & Gene Engineering Corp.,Ltd.? The latest ROE figure is 3.66%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Vcanbio Cell & Gene Engineering Corp.,Ltd., the total asset return on investment (ROA) is 2.48%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Vcanbio Cell & Gene Engineering Corp.,Ltd.'s latest financial report to see how their gross margin is doing - currently at 69.82%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Vcanbio Cell & Gene Engineering Corp.,Ltd., the net profit margin is 10.99%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data